Review decision
NICE considers sufficient new evidence has emerged to undertake a partial update of NICE's technology appraisal guidance on selective internal radiation therapies for treating hepatocellular carcinoma (TA688).
The appraisal started during late November 2023 with a consultation on the draft scope. It is then anticipated that the final scope will be released along with an invitation to participate in the appraisal during mid-December 2023.
See NICE's review decision paper for more details.
This page was last updated: